BioHarvest Sciences Research and Development Expenses 2020-2024 | BHST
BioHarvest Sciences research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
BioHarvest Sciences Annual Research and Development Expenses (Millions of US $) |
2023 |
$3 |
2022 |
$2 |
2021 |
$4 |
2020 |
$1 |
2019 |
$1 |
2019 |
$1 |
2018 |
$1 |
BioHarvest Sciences Quarterly Research and Development Expenses (Millions of US $) |
2024-06-30 |
$1 |
2024-03-31 |
$1 |
2023-12-31 |
$1 |
2023-09-30 |
$1 |
2023-06-30 |
$1 |
2023-03-31 |
$1 |
2022-12-31 |
$1 |
2022-09-30 |
$1 |
2022-06-30 |
$0 |
2022-03-31 |
$1 |
2021-12-31 |
$2 |
2021-09-30 |
$1 |
2021-06-30 |
$1 |
2021-03-31 |
$1 |
2020-12-31 |
$0 |
2020-09-30 |
$0 |
2020-06-30 |
$0 |
2020-03-31 |
$0 |
2019-12-31 |
|
2019-09-30 |
$0 |
2019-06-30 |
$0 |
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|